Daniela Gustinucci

Perugia, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Impact of differentiating between persistent and new infections on colposcopy referral in HPV-positive triage-negative women: results from the NTCC2 study.

Impact of differentiating between persistent and new infections on colposcopy referral in HPV-positive triage-negative women: results from the NTCC2 study.

Journal: Infectious agents and cancer
Published: July 04, 2025

Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study.

Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study.

Journal: Microbiology spectrum
Published: November 22, 2024

Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study.

Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study.

Journal: EBioMedicine
Published: August 08, 2023

Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial.

Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial.

Journal: International journal of cancer
Published: December 06, 2021

Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population.

Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population.

Journal: International journal of cancer
Published: May 31, 2021

Multicentre Evaluation of Hepika Test Clinical Accuracy in Diagnosing HPV-Induced Cancer and Precancerous Lesions of the Uterine Cervix.

Multicentre Evaluation of Hepika Test Clinical Accuracy in Diagnosing HPV-Induced Cancer and Precancerous Lesions of the Uterine Cervix.

Journal: Diagnostics (Basel, Switzerland)
Published: March 01, 2021

Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study.

Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study.

Journal: BJOG : an international journal of obstetrics and gynaecology
Published: December 08, 2020

Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population.

Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population.

Journal: Cancer cytopathology
Published: July 31, 2020

p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.

p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.

Journal: Journal of the National Cancer Institute
Published: November 15, 2019

Interlaboratory concordance of p16/Ki-67 dual-staining interpretation in HPV-positive women in a screening population.

Interlaboratory concordance of p16/Ki-67 dual-staining interpretation in HPV-positive women in a screening population.

Journal: Cancer cytopathology
Published: November 06, 2019

Cervical human papilloma virus (HPV) DNA primary screening test: Results of a population-based screening programme in central Italy.

Cervical human papilloma virus (HPV) DNA primary screening test: Results of a population-based screening programme in central Italy.

Journal: Journal of medical screening
Published: September 12, 2016

Interobserver reproducibility of cytologic p16INK4a /Ki-67 dual immunostaining in human papillomavirus-positive women.

Interobserver reproducibility of cytologic p16INK4a /Ki-67 dual immunostaining in human papillomavirus-positive women.

Journal: Cancer cytopathology
Published: August 25, 2016
Showing 1-12 of 17

Last Updated: 09/26/2026